07/01/2009 10:57 AM | Via: Boston Business Journal

Amag wins FDA approval for kidney drug

Amag Pharmaceuticals has won Food and Drug Administration approval for its drug to treat chronic kidney disease, called Feraheme. The Lexington, Mass.-based company’s drug is applied via an injection and is designed to be used as an iron replacement therapy to... read the full story

Bookmark and Share
See more breaking health news at Your Health Topics


Read more news about: Lexington, Massachusetts, Amag Pharmaceuticals, Food And Drug Administration


Comments



What we found in this article:

Lexington [...] chronic kidney disease, called Feraheme. The Lexington , Mass.-based company’s drug is applied via an [...]

Massachusetts [...] kidney disease, called Feraheme. The Lexington, Mass. -based company’s drug is applied via an injection [...]

Amag Pharmaceuticals [...] [...]

Add the latest local news to your website or blog

Grab the code for this widget